The creation of neo–liberal corporate bias in transnational medicines control
The Industrial shaping and interest dynamics of the European regulatory state
Bibliographic Data
| ID | 7771470 |
|---|---|
| Authors | GRAHAM LEWIS (University of Reading), John Abraham (0000-0003-3643-0128, University of Sussex), Julian Abraham (0000-0003-0643-0274) |
| Year | 2001 |
| Volume | 39 |
| Issue | 1 |
| Pages | 53-80 |
| Publication date | 2001-01-01 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | European Journal of Political Research (JOURNAL) |
| Journal identifiers | ISSN: 0304-4130 • E-ISSN: 1475-6765 |
| Publisher | Wiley (PUBLISHER • GB) |
| DOI | 10.1111/1475-6765.00569 |
| OpenAlex | W2092508367 |
| Language | EN |
| Citations received | 6 |
| References cited | 33 |
Drawing on the political theories of corporatism, neo–liberalism and pluralism, and on comparative empirical research in Brussels, Germany, Sweden and the UK, this article conceptualises the nature of Europeanised medicines regulation. It argues that a marketisation of regulation has been established in the European Union as a result of competition between national regulatory agencies for ‘regulatory business’ from the pharmaceutical industry. In the pharmaceuticals sector the Europeanised regulatory state is a product of three key factors: (a) the European Commission's commitment to an ‘efficiency’ regime which would meet the political objectives of a single European market and the commercial agendas of transnational pharmaceutical companies, (b) the endemic corporate bias associated with medicines regulation in the most influential member states, and (c) the considerable success of neo–liberal politics across a number of major member states, including Germany, Sweden and the United Kingdom
Corporatism · Economics · European commission · European union · International trade · Market economy · Pluralism (philosophy · Political economy · Political science · Politics · State (computer science · Law · Pharmaceutical Economics and Policy · Pharmaceutical industry and healthcare · Political Influence and Corporate Strategies · Public Administration
The Reconfiguration of Risk in the British State
Public-private partnerships and the politics of alcohol policy in England
Supranational regulatory agencies between independence and control
Thalidomide, BSE and the single market
Enlargement Waves’ and Interest Group Participation in the EU Policy-Making System
Pharmaceuticals in Australia
Science, politics, and the pharmaceutical industry
Politics in industrial society
The uniting of Europe
Responsive Regulation
Regulating Europe
Trading Up
Uniting Of Europe
Alan Cawson, Corporatism and Political Theory, Oxford
The rise of the regulatory state in Europe
Regulatory compliance and capitalist diversity in Europe
Globalization, corporate identity and European technology policy 1
Market-making policy in Europe
Introduction
The accommodation of diversity in European policy‐making and its outcomes
The state and interest groups in a framework of multi‐level decision‐making
Policy-making by subterfuge
National parliaments and EU Affairs Committees
Towards a European regulatory state
Community and autonomy
International Integration
Harmonization of social policies and social regulation in the European Community
Networking requirements, institutional capacity, and implementation gaps in transitional regimes
European integration and supranational governance
The shift to the right
The rise and decline of corporatism
Pharmaceutical regulation in Denmark and the UK
| Unique citing works | 6 |
|---|---|
| Citations per year | 0.27 |
| Citation span | 2004 - 2019 (16) |
| Citation velocity | historical |
| Highly cited | No |
| Citation types | Neutral: 6 |